Results: RHD 1056C>G was predicted to cause the formation of an exonic splicing silencer (ESS) site. The creation of new ESS site potentially inhibits the splicing event, resulting alteration of splicing. This is similar to remodeling of splice acceptor or donor site, as this kind of deep exonic variation could affect the D antigen's quality or quantity. This is in concordance with serologic results, which showed only delayed weak agglutination to anti-D reagents.
Conclusions:
The analytic methods we applied showed good correlation with the actual phenotype, along with concordant results when analyzing other known variants reported in the literature. We conclude that RHD 1056C>G results in serologic weak D phenotype.
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| INTRODUCTION
ESS, exonic splicing silencer; ESE, exonic splicing enhancer; WT, wild type.
The table was merged from results of Oncotator, wANNOVAR and HSF.
visited our hospital for removal of nasal polyp. The observed synonymous variation was analyzed to result in weakened or partial D expression, and we performed a comprehensive analysis of all synonymous variations in the literature. 
| METHODS

| RESULTS
| Serologic and genotype results
Routine preoperation D blood group showed strong 4+ reaction by the automated QWALYS-3 device, with reagents provided by the manufacturer. This was backed up with manual tubes tests. Initially, manual tests did not show agglutination, but later showed weak 1+ reaction was observed with prolonged 15-min incubation. Genotyping 
| In silico analysis of all synonymous variations
A review of all reported RHD single nucleotide variants without amino acid change was done. Annotation using wANNOVAR and Oncotator was performed for all 14 variations with annotation with the hg19 ref-
erence. Interestingly, four cases were found as with splice site mutation around exon-intron junctions (Table 1 ). All these variations were located within 2 base pairs on the exon side from exon-intron splicing junction. The other nine variations, including this case, were predicted as a silent mutation in wANNOVAR and Oncotator (Table 1) . Further F I G U R E 2 An example of RHD splice site mutation, RHD:c.1227G>A. (A) Comparing reference sequence, the G sequence was changed to A sequence. It is located by the exon-intron junction, and Oncotator determined the change as splice site mutation. (B) In detailed analysis using Human Splicing Finder (HSF) predicted several signal for potential splice sites. Using HSF matrices, two acceptor motif changes and two donor motif changes were predicted. Upper case and lower case letters in motif represents exonic sequences and intronic sequences, respectively. Motif change in acceptor or donor site could result whole or partial exon deletion, insertion, frame-shift, and truncation of RHD, which could result in change of RHD protein quality or quantity. In Maximum Entropy (MaxEnt) method, 5′ motif which represents donor site were predicted to be broken with MaxEnt variation, −34.63%. MaxEn, maximum entropy; WT, wild type in silico analysis was done with HSF. Using the method, we additionally found two more variations were related with making new donor site or new acceptor site (Table 1) .
| Analysis of RHD c.1056C>G
We have also found that seven cases were predicted to be related with ESS site formation or ESE site breakage. The case of c.1056C>G in this study were predicted to be related with new ESS site formation (Table 1) , despite being a synonymous variation in amino acid change ( Figure 1A ). In this case, the creation of new exonic ESS site potentially inhibits the splicing event, resulting alteration of splicing. This is similar to remodeling of splice acceptor or donor site, as this kind of deep exonic variation could affect the D antigen's quality or quantity.
In detailed analysis using HSF, the tool predicted three signals for the creation of a new exonic ESS site. ESS could inhibit splicing of the premRNA, contributing to alternate splicing. Alternate splicing could affect mRNA quality or stability through whole/partial exon deletion, insertion, frame-shift, and truncation. Three different prediction algorithms 
| DISCUSSION
This study has shown that all but one known synonymous variations reported to be causative of weak D phenotype was related with exonic splicing donor site or acceptor site alteration. The new case reported by this study, RHD c.1056C>G, was analyzed to have splicing changes regarding the exofacial region of the exon 7 to be a main reason. However, further experimental validation such as transcriptome analysis could be required to fully understand the impact of this new variant. Nevertheless, our finding highlights that synonymous variations in RHD should be re-evaluated in silico or in vitro when found with weak RHD phenotype.
A good example for the validation of our applied methods was done by in silico analysis on the Asia type DEL phenotype. This variation is possibly the best investigated of synonymous variants that cause splicing change in the RHD gene; skipping of transcription of exon 9 in RHD c.1227G>A individuals was observed, [11] [12] [13] and this variant has apparently identical epitopes of the D antigen in extremely low levels. 11, 14, 15 This variation has a changed sequence placed in the junction region of exon 9 and its following intron (Figure 2A ). The prediction of potential splice sites in HSF were inferred from two methods, using HSF matrices ( Figure 2B , upper table) and using maximum entropy calculation ( Figure 2B , lower table). In Figure 2B , remodeling of splice acceptor and donor site was predicted, suggesting the aberrant splicing of RHD exon, identical to previous experiment results. The aberrant splicing is speculated to affect D protein quality or quantity through altering RNA stability, which may have resulted in the extremely low levels of D antigen expression. This variant was also predicted to have multiple splice donor and acceptor changes, compared to other variants ( 17 However, these diverse mechanisms were difficult to predict or validate and it was considered beyond the scope of this study.
Location of the variant also seemed to play as a factor in synonymous changes with weakened D antigen expression. Four variations were located in the exofacial region ( Table 1 Table 1 ).
In conclusion, we report a new RHD allele with apparent synonymous variation which resulted in partial D phenotype, and validated the effect of the variation with in silico methods. We further evaluated other synonymous variations and concluded that good correlation with prediction and actual phenotype.
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